New England Research & Management, Inc. Pfizer Inc Transaction History

New England Research & Management, Inc.

$213 Million
Q3 2024

A detailed history of New England Research & Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, New England Research & Management, Inc. holds 74,463 shares of PFE stock, worth $1.96 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

74,463

Previous 74,252 0.28%

Holding current value

$1.96 Million

Previous $2.08 Million 3.71%

% of portfolio

1.01%

Previous 1.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$27.7 - $31.39 $5,844 - $6,623	211 Added 0.28%	74,463 $2.16 Million
Q2 2024 Jul 09, 2024	SELL	$25.26 - $29.6 $151,989 - $178,103	-6,017 Reduced 7.5%	74,252 $2.08 Million
Q1 2024 Apr 16, 2024	BUY	$25.89 - $29.73 $189,488 - $217,593	7,319 Added 10.03%	80,269 $2.23 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $154,167 - $200,246	-5,900 Reduced 7.48%	72,950 $2.1 Million
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $57,762 - $67,518	-1,800 Reduced 2.23%	78,850 $2.62 Million
Q2 2023 Jul 05, 2023	BUY	$36.12 - $41.79 $204,981 - $237,158	5,675 Added 7.57%	80,650 $2.96 Million
Q1 2023 Apr 06, 2023	BUY	$39.39 - $51.28 $47,149 - $61,382	1,197 Added 1.62%	74,975 $3.06 Million
Q4 2022 Jan 09, 2023	SELL	$41.75 - $54.5 $14,195 - $18,530	-340 Reduced 0.46%	73,778 $3.78 Million
Q3 2022 Oct 06, 2022	SELL	$43.76 - $53.42 $15,053 - $18,376	-344 Reduced 0.46%	74,118 $3.24 Million
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $247,027 - $292,897	-5,309 Reduced 6.66%	74,462 $3.9 Million
Q1 2022 Apr 20, 2022	BUY	$45.75 - $56.69 $159,621 - $197,791	3,489 Added 4.57%	79,771 $4.13 Million
Q4 2021 Jan 05, 2022	BUY	$41.32 - $61.25 $13,429 - $19,906	325 Added 0.43%	76,282 $4.5 Million
Q3 2021 Oct 08, 2021	BUY	$39.25 - $50.42 $265,918 - $341,595	6,775 Added 9.79%	75,957 $3.27 Million
Q2 2021 Jul 15, 2021	SELL	$35.91 - $40.68 $105,108 - $119,070	-2,927 Reduced 4.06%	69,182 $2.71 Million
Q1 2021 Apr 16, 2021	SELL	$33.49 - $37.77 $49,531 - $55,861	-1,479 Reduced 2.01%	72,109 $2.61 Million
Q4 2020 Jan 07, 2021	SELL	$33.47 - $42.56 $307,388 - $390,871	-9,184 Reduced 11.1%	73,588 $2.71 Million
Q3 2020 Oct 08, 2020	SELL	$31.75 - $37.25 $10,699 - $12,553	-337 Reduced 0.41%	82,772 $3.04 Million
Q2 2020 Jul 15, 2020	BUY	$30.12 - $36.54 $551,196 - $668,682	18,300 Added 28.24%	83,109 $2.72 Million
Q1 2020 Jun 15, 2020	BUY	$27.03 - $38.62 $262,191 - $374,614	9,700 Added 17.6%	64,809 $2.12 Million
Q4 2019 Jan 14, 2020	SELL	$32.92 - $37.36 $5,761 - $6,538	-175 Reduced 0.32%	55,109 $2.16 Million
Q3 2019 Nov 04, 2019	BUY	$32.49 - $42.13 $207,936 - $269,632	6,400 Added 13.09%	55,284 $1.99 Million
Q2 2019 Jul 09, 2019	SELL	$36.98 - $41.52 $9,245 - $10,380	-250 Reduced 0.51%	48,884 $2.12 Million
Q1 2019 Apr 03, 2019	SELL	$37.5 - $41.2 $73,312 - $80,546	-1,955 Reduced 3.83%	49,134 $2.09 Million
Q4 2018 Jan 11, 2019	SELL	$38.47 - $43.86 $32,699 - $37,281	-850 Reduced 1.64%	51,089 $2.23 Million
Q3 2018 Oct 03, 2018	BUY	$34.47 - $41.81 $1,723 - $2,090	50 Added 0.1%	51,939 $2.29 Million
Q2 2018 Jul 05, 2018	SELL	$32.98 - $35.16 $111,043 - $118,383	-3,367 Reduced 6.09%	51,889 $1.88 Million
Q1 2018 Apr 17, 2018	SELL	$31.91 - $37.02 $9,573 - $11,106	-300 Reduced 0.54%	55,256 $1.96 Million
Q4 2017 Jan 09, 2018	SELL	$33.26 - $35.29 $451,238 - $478,779	-13,567 Reduced 19.63%	55,556 $2.01 Million
Q3 2017 Oct 25, 2017	BUY	$31.0 - $34.15 $2.14 Million - $2.36 Million	69,123	69,123 $2.47 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.

Account

New England Research & Management, Inc. Pfizer Inc Transaction History